Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance
dc.contributor.author | Charles-Schoeman, Christina | |
dc.contributor.author | Buch, Maya H. | |
dc.contributor.author | Dougados, Maxime | |
dc.contributor.author | Bhatt, Deepak L. | |
dc.contributor.author | Giles, Jon T. | |
dc.contributor.author | Ytterberg, Steven R. | |
dc.contributor.author | Koch, Gary G. | |
dc.contributor.author | Vranic, Ivana | |
dc.contributor.author | Wu, Joseph | |
dc.contributor.author | Wang, Cunshan | |
dc.contributor.author | Kwok, Kenneth | |
dc.contributor.author | Menon, Sujatha | |
dc.contributor.author | Rivas, Jose L. | |
dc.contributor.author | Yndestad, Arne | |
dc.contributor.author | Connell, Carol A. | |
dc.contributor.author | Szekanecz, Zoltán | |
dc.date.accessioned | 2022-09-27T10:19:28Z | |
dc.date.available | 2022-09-27T10:19:28Z | |
dc.date.issued | 2022 | |
dc.date.oa | 2023-06-27 | |
dc.date.pasync | 2023-02-23T00:06:52Z | |
dc.date.updated | 2022-09-27T10:19:27Z | |
dc.description.corrector | LB | |
dc.identifier.citation | Annals Of The Rheumatic Diseases. -82 : 1 (2022), p. 119-129. -Ann. Rheum. Dis. - 0003-4967 | |
dc.identifier.doi | http://dx.doi.org/10.1136/ard-2022-222259 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM103789 | |
dc.identifier.scopus | 85139865478 | |
dc.identifier.uri | https://hdl.handle.net/2437/337290 | |
dc.identifier.url | https://ard.bmj.com/lookup/doi/10.1136/ard-2022-222259 | |
dc.identifier.wos | 000859802100001 | |
dc.language | eng | |
dc.rights.access | open access article | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_1_ard-2022-222259.full with Suppl.pdf
- Méret:
- 4.13 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Kiadói változat